Contract award · 8 Nov 2023

NP92520b Aflibercept (Eylea®)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded “Aflibercept (Eylea®)” to Bayer Plc for £54.7m.

No competitionMedical equipment & pharmaceuticalsScotland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Supplier
Bayer Plc
Value
£54,711,495
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Timeline
  1. Contract date8 Nov 2023
  2. Published28 Nov 2023Published 20 days after the contract date

Description

The Framework Agreement is for the supply of Aflibercept (Eylea®) solution for injection vials to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement. The Framework Participant is required to supply Goods to designated delivery points throughout Scotland for use by Participating Authorities.

About the supplier

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

All contracts

More won by Bayer Plc

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview